Glioblastoma pharmacotherapy: A multifaceted perspective of conventional and emerging treatments (Review)-Reference-Cited by-同舟云学术

Glioblastoma pharmacotherapy: A multifaceted perspective of conventional and emerging treatments (Review)

Published:2021-10-06 Issue:6 Volume:22 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Sevastre Ani-Simona¹,Costachi Alexandra²,Tataranu Ligia³,Brandusa Corina²,Artene Stefan²,Stovicek Olivian⁴,Alexandru Oana⁵,Danoiu Suzana⁶,Sfredel Veronica⁷,Dricu Anica²

Affiliation:

1. Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania

2. Department of Biochemistry, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania

3. Department of Neurosurgery, ‘Bagdasar‑Arseni’ Emergency Clinical Hospital, 041915 Bucharest, Romania

4. Department of Pharmacology, Faculty of Nursing Targu Jiu, Titu Maiorescu University of Bucharest, 210106 Targu Jiu, Romania

5. Department of Neurology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania

6. Department of Pathophysiology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania

7. Department of Physiology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural, quantum chemical, spectroscopic (UV, FT-IR, and NMR), and molecular docking studies of novel azo compounds;Journal of Molecular Structure;2025-01

2. Evaluation of Single and Combined Temozolomide and Doxorubicin Treatment Responses in Low- and High-Grade Glioma In Vitro;Cureus;2024-08-15

3. First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax);Frontiers in Immunology;2024-08-13

4. Bevacizumab for Glioblastoma Multiforme: A Literature Review;JAP Academy Journal;2024-06-01

5. High expression of BTN3A1 is associated with clinical and immunological characteristics and predicts a poor prognosis in advanced human gliomas;Frontiers in Immunology;2024-05-28